ATP13A3变体通过破坏聚胺运输来促进肺动脉高血压
Bin Liu1, Mujahid Azfar2, Ekaterina Legchenko1
1Section of Cardio and Respiratory Medicine, Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, Papworth Road, Cambridge CB2 0BB, UK.
Cardiovascular research
|April 16, 2024
概括
失去ATP13A3功能会损害内皮细胞中的聚胺运输,导致功能障碍和肺动脉高血压 (PAH). 这突出了ATP13A3的特点.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 心血管研究研究心血管研究
背景情况:
- ATP13A3,一种P5B类型的ATPase,与聚胺运输有关,但其确切的功能尚不清楚.
- 在肺动脉高血压 (PAH) 患者中发现了ATP13A3的功能丧失变体.
研究的目的:
- 阐明ATP13A3在血管内皮细胞 (ECs) 中的生物功能.
- 为了研究PAH相关的ATP13A3变体如何促进疾病的发病.
主要方法:
- 在各种EC模型中研究ATP13A3缺乏和过度表达,包括患者衍生细胞.
- 产生了转基因小鼠以评估体内PAH发展.
- 利用基于细胞的测试来评估聚胺运输,EC增殖,细胞亡和透性.
主要成果:
- ATP13A3局限于ECs中的回收内分体,并调节基底聚胺含量.
- 缺少ATP13A3会影响聚胺的吸收,减少EC的扩散,增加细胞亡,增强单层透性.
- 与PAH相关的ATP13A3变体表现出功能丧失的表型.
- 具有相关Atp13a3变异的小鼠自发地发展出PAH.
结论:
- ATP13A3在EC中起到关键的聚胺转运体的作用,维持聚胺平衡.
- 缺少ATP13A3会导致EC功能障碍,并导致PAH的发生.
- 针对聚胺失衡和EC功能障碍的向疗法是PAH治疗的必要条件.
更多相关视频
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
156
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
156
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
150
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
150
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
160
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
160
Pulmonary Hypertension: Classification and Pathogenesis
173
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
173
Translation
141.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.9K
ATP Synthase: Mechanism
14.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.6K


